More from the Company Monthly Newsletter January 2020
We welcome a new, eventful and exciting 2020!
During the first month of the decade, we have continued our development and documentation work. Negotiations regarding our long-term financing have continued, meetings with some subcontractors have been held, and we haveworked with the preparations for further patent applications as well as the application to the Swedish Medical Products Agency relating to our positioning strap (Class 1) that will be submitted in the next few weeks.
We started the year by visiting the factory where our Nasal Cooling Kits, the disposable items, will be produced. We save both time and ensure quality when using the machines we bought at the end of last year. The production of the first balloon catheters has worked well. We are very pleased with our cooperation with them.
The discussions regarding our long-term funding have continued with different parties and alternatives. We will publish updated information within a few weeks.
We have met with two subcontractors to discuss prices, forecasts and technical solutions.
We are preparing the documentation required for two different patent applications. We intend to submit one patent application during the month of March and the other during the month of April.
Additionally, we have been working on completing the technical file for the positioning strap (Class 1 product, which is part of the Nasal Cooling Kit) so that we can submit the application to the Swedish Medical Products Agency (Läkemedelsverket) next month.
The global sales of cooling systems amounted to more than USD 1,013 Million in 2018 and is estimated to grow at a CAGR of 6.34% between 2020-2027.
Good, positive growth in all markets in the next few years! Källa: www.ResearchNester.com
We are looking forward to a successful new decade, starting with 2020!
Follow us on LinkedIn. Additional information about QuickCool and our solution may be found on our homepage: http://www.quickcool.se/en/home.html
Kind regards,
Fredrik
Fredrik Radencrantz
CEO
QuickCool AB
Ideon Science Park
Beta 6, Scheelevägen 17 - SE-223 70 Lund - Sweden
E-mail: fredrik.radencrantz@quickcool.se Web: www.quickcool.se
Mobile +46 (0)73 834 1188
QuickCool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the QuickCool® SYSTEM. QuickCool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. QuickCool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool